Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030070 | SCV000052725 | benign | Neonatal diabetes mellitus | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Benign. |
Prevention |
RCV000249140 | SCV000302990 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001588831 | SCV001824891 | likely benign | not provided | 2018-09-04 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000249140 | SCV002071429 | benign | not specified | 2018-04-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001588831 | SCV002406737 | benign | not provided | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002464076 | SCV002605397 | benign | Neonatal insulin-dependent diabetes mellitus | criteria provided, single submitter | research | Mutations in INS gene can cause early onset diabetes mellitus which is insulin dependent. May have poor response to sulfonylureas, as this mutation can cause beta cell destruction. However no sufficient evidence is found to ascertain the role of this particular variant rs5507, yet. | |
Fulgent Genetics, |
RCV002496459 | SCV002805746 | likely benign | Type 1 diabetes mellitus 2; Maturity-onset diabetes of the young type 10; Hyperproinsulinemia; Diabetes mellitus, permanent neonatal 4 | 2021-11-02 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001588831 | SCV004564047 | benign | not provided | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001588831 | SCV005223142 | likely benign | not provided | criteria provided, single submitter | not provided |